期刊文献+

活化CD40信号上调胃癌细胞株PD-L1表达及其生物学功能

CD40 activation up-regulates PD-L1 expression on gastric cancer cells and its biological significance
下载PDF
导出
摘要 目的观察CD40信号活化后胃癌细胞株增殖凋亡及其表面分子的变化情况并探讨其生物学意义。方法以高表达CD40分子的胃癌细胞株AGS和低表达CD40分子的BGC-823为研究对象,以可溶性CD40配体(sCD40L)激发细胞CD40信号,流式细胞术测定激发CD40信号前后胃癌细胞表面PD-L1分子的表达情况和CD8+T淋巴细胞的表型变化;采用台盼蓝染色法比较CD40活化前后胃癌细胞对CD8+T淋巴细胞的抑制效应。结果 1)CD40信号活化可以诱导高表达CD40分子的胃癌细胞株AGS周期阻滞;2)CD40信号活化可上调AGS细胞表面PD-L1分子的表达,而对低表达CD40分子的细胞BGC-823无上调效应。3)AGS细胞表面PD-L1分子上调明显抑制CD8+T淋巴细胞的增殖并下调其表面CD25分子的表达。结论 CD40信号活化可上调胃癌细胞表面PD-L1表达,继而诱导效应细胞的数量和功能下降,最终有利于胃癌发生免疫逃逸。 This paper aimed to observe proliferation, apoptosis, and surface molecules changes of gastric cancer cell after activation of CD40 signaling, and evaluate its biological significance. Firstly gastric cancer cell lines AGS with high expression of CD40 and BGC-823 but low expression of CD40 were stimulated with soluble CD40 ligand (sCD40L). Then PD-L1 molecules expression and CD8 + T lymphocytes phenotypic changes were measured by flow cytometry before and after CD40 signal molecule activation. Finally, trypan blue staining method was employed to evaluate the inhibitory effects of gastric cancer cell lines AGS with high expression of the PD-L1 molecule on CD8+ T lymphocytes. We got the following results: l) CD40 signal activation can induce cycle arrest of gastric cancer cell line AGS with high expression of CD40; 2) CD40 signal activation could up-regulate cell surface molecule expression of PD-L1 on AGS with high expression of CD40, but no effective for BGC-823 with low expression of CD40; 3) AGS could inhibit the proliferation and down-regulate expression of the CD25 molecule of CD8+T lymphocytes significantly through cell surface PD-L1 molecules. In conclusion, CD40 signal activation can up-regulate the expression of PD-L1 on gastric cancer cell surface, and then induce decline in the number and function of tumor-killing T cells, and ultimately contribute to gastric cancer immune escape.
出处 《免疫学杂志》 CAS CSCD 北大核心 2013年第5期400-403,共4页 Immunological Journal
基金 苏州市卫生局科教兴卫(SWKQ1001) 江苏省普通高校研究生科研创新计划(CXZZ11_0119) 国家自然基金(31270919)
关键词 CD40 PD-L1 胃癌 免疫逃逸 CD40 PD-L1 Gastric cancer Immune escape
  • 相关文献

参考文献15

  • 1Kanat O, O'Neil BH. Metastatic gastric cancer treatment: little slow but worthy progress[J]. Med Oncol, 2013, 30(11 464.
  • 2Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J] CA Cancer J Clin, 2013, 63(1): 11-30.
  • 3Dumas G, Dufresne M, Asselin E, et al. CD40 pathww. activation reveals dual function for macrophages in humat endometrial cancer cell survival and invasion [J]. Cance Immunol Immunother, 2012, 62(2): 273-283.
  • 4Li R, Chen WC, Pang XQ, et al. CD40 signal expression its gastric cancer tissue and its correlation with prognosis o gastric cancer patients[J]. Mol Biol Rep, 2012, 39(9): 8741- 8747.
  • 5He S, Zhao H, Fei M, et al. Expression of the eo-signaling molecules CD40-CD40L and their growth inhibitory effect on pancreatic cancer in vitro[J]. Oncol Rep, 2012, 28(1): 262-268.
  • 6庞雪芹,陈卫昌,李锐,岑建农.激发CD40信号对胃癌细胞株生长增殖及基因表达谱的影响[J].中华消化杂志,2007,27(11):732-735. 被引量:3
  • 7文丽君,刘海燕.淋巴细胞表面CD40分子的表达和作用[J].免疫学杂志,2011,27(5):448-450. 被引量:3
  • 8Khong A, Nelson D J, Nowak AK, et al. The use of agonistic anti-CD40 therapy in treatments for cancer[J]. Int Rev Immunol, 2012, 31(4): 246-266.
  • 9赵伟庆,吴昌平.分子突变体在胃癌中的表达及临床意义[D].苏州大学硕士学位论文,2006.
  • 10Shi F, Shi M, Zeng Z, et al. PD-1 and PD-LI upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients [J]. Int J Cancer, 2011, 128(4): 887-896.

二级参考文献43

  • 1王兰兰,陈捷,冯伟华,蔡蓓,唐江涛.共刺激分子CD40L在RA患者T细胞亚群中的异常表达[J].免疫学杂志,2004,20(4):294-296. 被引量:2
  • 2童彤,宋咏梅,付明,董立佳,金顺钱,吴旻,詹启敏.Gadd45表达对肿瘤细胞HCT116生长的抑制作用及其机理[J].中华医学杂志,2003,83(21):1895-1899. 被引量:4
  • 3蔡鹏威,林芸,窦敏,陈金花,林一.CD40-CD40L在强直性脊柱炎患者外周血淋巴细胞上的表达[J].免疫学杂志,2005,21(6):507-508. 被引量:3
  • 4吕有勇.关于我国胃癌基础与临床研究模式的思考[J].中华医学杂志,2006,86(46):3245-3248. 被引量:4
  • 5Giandomenica I, Ivo S, Franziska A, et al. CD40-CD40L cross- talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4^+ T cells. PNAS, 2009, 106: 876-881.
  • 6Kondo E, Gryschok L, Klein-Gonzalez N. CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential. Clin Exp Immunol, 2009,155 : 249-256.
  • 7Barnes DM, Meyer JS, Gonzalez JG, et al. Relationship between c-erbB-2 immunoreactivity and thymidine labeling index in breast carcinoma in situ. Breast Cancer Res Treat, 1991, 18: 11-17.
  • 8Bohuslav M, Rebecca P, Stacie G, et al. Expression of CD40 and growth-inhibitory activity of CD40 ligand in ovarian cancer cell lines. Gynecol Oncol, 2007, 104:707-713.
  • 9Wu Y, Wang L, He X, et al. Expression of CD40 and growth- inhibitory activity of CD40 ligand in colon cancer ex vivo. Cell Immunol, 2008,253 : 102-109.
  • 10Aristides M, Maria K, Pauline GK, et al. CD40 Induces antigen transporter and immunoproteasome gene expression in carcinomas via the coordinated action of NF-KB and of NF-KB-mediated De Novo synthesis of IRF-1. Mol Cell Biol, 2008, 28: 6208-6222.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部